|
Faculty, University of Wisconsin School of Medicine and Public Health
Dr. Kahl is an Assistant Professor of Medicine at the University of Wisconsin. He is the Director of the UW
Lymphoma Service and Clinical Research Director for Hematologic Malignancies for the University of
Wisconsin Paul P. Carbone Comprehensive Cancer Center. He received his medical degree from Tufts
University where he was elected AOA. He completed all post-graduate training at the University of
Wisconsin. Dr. Kahl is certified by the American Board of Internal Medicine in both Internal Medicine and
Hematology. His clinical interests involve the care of patients with Hodgkin lymphoma, non-Hodgkin's
lymphoma and chronic lymphocytic leukemia. He is a member of several professional organizations
including the American Society of Hematology, the American Society of Clinical Oncology and the Eastern
Cooperative Oncology Group.
| UW Health Clinics |
|
Hematology Clinic
|
 (608) 265-1700
(800) 323-8942
|
UW Carbone Cancer Center
|
Map
|
Wayfinding
|
| Procedures |
|
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Bone Marrow Biopsy, Chemotherapy, Lumbar Puncture
|
| Languages Spoken |
|
English
|
|
Medical interpreters are available to help
patients communicate with hospital and clinic staff.
For more information, please contact
interpreter services at (608) 262-9000.
|
|
Professional Certifications and Education
|
| Board Certification |
Internal Medicine
Hematology
|
| Fellowship |
University of Wisconsin Hospital and Clinics
|
| Residency |
University of Wisconsin Hospital and Clinics
|
| Internship |
University of Wisconsin Hospital and Clinics
|
| Medical School |
Tufts University, Boston
|
|
Hospital Affiliations
|
| Primary Affiliation(s) |
University of Wisconsin Hospital and Clinics
|
| Secondary Affiliation(s) |
Veterans Hospital - Wm. S. Middleton Memorial
|
| Research |
| Dr. Kahl's research focuses on the development of novel treatments for lymphoma patients, with
emphasis on the development of targeted therapies. He is the principal investigator of multiple clinical
trials at the University of Wisconsin. He serves on the Eastern Cooperative Oncology Group Lymphoma
Core Committee and is the principal investigator of ECOG study 4402, Rituximab Extended Schedule or
Retreatment Trial (RESORT). |
| UW School of Medicine and Public Health |
| Medicine |
|
